Document is current
Any future updates will be listed below
-
Authors
Olivieri, Daniel J. https://orcid.org/0000-0003-2684-4941
Berridge-Green, Alexis
Othus, Megan https://orcid.org/0000-0001-8176-6371
Radich, Jerald P. https://orcid.org/0000-0002-1618-230X
Advani, Anjali S. https://orcid.org/0000-0003-0015-5902
Erba, Harry P.
Walter, Roland B. https://orcid.org/0000-0002-9268-3341
-
Funding
Funding for this research was provided by:
American Society of Hematology (ASH HONORS Award (DJO))
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U10-CA180888, U10-CA180819)
- License Information
-
More Information
Article History
Received: 21 January 2025
Revised: 16 April 2025
Accepted: 23 April 2025
First Online: 3 May 2025
Competing interests
: The authors declare no competing interests.
: This retrospective research was conducted under a research protocol approved by the Institutional Review Board of the Fred Hutchinson Cancer Center (FHCC; #2562). The study was conducted in accordance with the Declaration of Helsinki and other relevant guidelines and regulations. All patients studied provided written informed consent for participation in a SWOG clinical trial.
